Nurse Practitioner · Lebanon, NH
NPI
1104803899
Since 2005
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1 Medical Center Dr
Lebanon, NH, 03756
Phone (603) 650-5104
Medicare paid, 2024
$13K
240 services
Medicare patients, 2024
132
Average age 64
Drug cost, 2024
$647K
1,422 prescriptions
Company payments, 2024
$264
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Denise McGrath was code 99213 (office e&m - established), 63 times for 60 patients. In total Denise McGrath billed 240 services in 10 codes, and Medicare paid $13K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 63 | 60 | $43.15 | $2,718 |
| 99214 Office E&M - Established | Office | 52 | 40 | $55.87 | $2,905 |
| 64615 Musculoskeletal | Office | 47 | 26 | $75.74 | $3,560 |
| 99215 Office E&M - Established | Office | 41 | 40 | $77.47 | $3,176 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 12 | 12 | $9.05 | $109 |
By year: 2022 $16K for 277 services; 2023 $16K for 276 services; 2024 $13K for 240 services.
Medicare prescription drug claims, 2024
In 2024, the drug Denise McGrath prescribed most often to Medicare patients was Emgality Pen (Galcanezumab-Gnlm), with 173 prescriptions and refills. In total Denise McGrath wrote 1,422 Medicare prescriptions that cost $647K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Emgality Pen Galcanezumab-Gnlm | 173 | 184 | 22 | $127K |
| Ajovy Autoinjector Fremanezumab-Vfrm | 140 | 148 | 15 | $102K |
| Nurtec Odt Rimegepant Sulfate | 122 | 122 | 33 | $128K |
| Gabapentin Generic | 122 | 169 | 25 | $1,907 |
| Aimovig Autoinjector Erenumab-Aooe | 92 | 96 | 14 | $68K |
| Qulipta Atogepant | 81 | 87 | 16 | $91K |
| Topiramate Generic | 75 | 122 | 14 | $882 |
| Ubrelvy Ubrogepant | 61 | 61 | 19 | $65K |
| Rizatriptan Rizatriptan Benzoate | 44 | 45 | 17 | $587 |
| Baclofen Generic | 44 | 44 | 19 | $393 |
| Sumatriptan Succinate Generic | 40 | 42 | 19 | $1,368 |
| Zonisamide Generic | 36 | 42 | Under 11 | $440 |
| Amitriptyline Hcl Generic | 35 | 55 | Under 11 | $329 |
| Ajovy Syringe Fremanezumab-Vfrm | 33 | 33 | Under 11 | $23K |
| Carbamazepine Er Carbamazepine | 24 | 35 | Under 11 | $1,945 |
Brand drugs: 728 claims; generic drugs: 694 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Denise McGrath $264 ($264 in general payments such as food, travel and fees) from 2 companies. The largest payer was Pfizer Inc. with $181.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.